Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Early screening and HPV vaccination reduce cervical cancer risk.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Targeting DNA methylation can help treat skin disorders and cancers.

Further research is needed to develop effective cancer prevention strategies.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

WNT10B is important for body functions and linked to diseases like osteoporosis, obesity, and cancer.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Bicalutamide may help treat female pattern hair loss.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.